J. Tota, M. Chevarie-davis, and L. Richardson, Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies, Preventive Medicine, vol.53, pp.12-21, 2011.
DOI : 10.1016/j.ypmed.2011.08.017

P. Gravitt, The known unknowns of HPV natural history, Journal of Clinical Investigation, vol.121, issue.12
DOI : 10.1172/JCI57149

I. Agency, . Research, and . Cancer, Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, 2007.

M. Khan, P. Castle, and A. Lorincz, The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice, JNCI Journal of the National Cancer Institute, vol.97, issue.14, pp.1072-1079, 2005.
DOI : 10.1093/jnci/dji187

S. Vinokurova, N. Wentzensen, and I. Kraus, Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions, Cancer Research, vol.68, issue.1, pp.307-313, 2008.
DOI : 10.1158/0008-5472.CAN-07-2754

C. Moody and L. Laimins, Human papillomavirus oncoproteins: pathways to transformation, Nature Reviews Cancer, vol.367, issue.8, pp.550-560, 2010.
DOI : 10.1038/nrc2886

B. Romanowski, Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines, Human Vaccines, vol.7, issue.2, pp.161-169, 2011.
DOI : 10.4161/hv.7.2.13690

F. Bosch, Human papillomavirus: science and technologies for the elimination of cervical cancer, Expert Opinion on Pharmacotherapy, vol.84, issue.3, pp.2189-2204, 2011.
DOI : 10.1586/eog.10.42

S. Garland and J. Smith, Human Papillomavirus Vaccines, Drugs, vol.302, issue.7, pp.1079-1098, 2010.
DOI : 10.2165/10898580-000000000-00000

J. Brotherton and D. Gertig, Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact, Expert Review of Anti-infective Therapy, vol.9, issue.8, pp.627-639, 2011.
DOI : 10.1586/eri.11.78

J. Smith, L. Lindsay, and B. Hoots, Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update, International Journal of Cancer, vol.189, issue.3, pp.621-632, 2007.
DOI : 10.1002/ijc.22527

N. Li, S. Franceschi, and R. Howell-jones, Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication, International Journal of Cancer, vol.201, issue.Suppl. 10, pp.927-935, 2011.
DOI : 10.1002/ijc.25396

E. Barrios, J. Vassallo, and R. Alonso, III Atlas de Incidencia de cáncer en el Uruguay Registro Nacional de CáncerVComisión Honoraria de Lucha Contra el Cáncer, 2002.

P. De-cremoux, A. De-la-rochefordière, and A. Savignoni, Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype, International Journal of Cancer, vol.357, issue.4
DOI : 10.1002/ijc.24075

F. Bosch, M. Manos, and N. Munoz, Prevalence of Human Papillomavirus in Cervical Cancer, Obstetrical & Gynecological Survey, vol.50, issue.10, pp.796-802, 1995.
DOI : 10.1097/00006254-199510000-00015

J. Walboomers, M. Jacobs, and M. Manos, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, The Journal of Pathology, vol.89, issue.1, pp.12-19, 1999.
DOI : 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

B. Bertelsen, K. Kugarajh, and R. Skar, HPV subtypes in cervical cancer biopsies between 1930and 2004: detection using general primer pair PCR and sequencing, Virchows Archiv, vol.57, issue.2, pp.141-147, 2006.
DOI : 10.1007/s00428-006-0232-3

S. De-sanjose, W. Quint, and L. Alemany, Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, The Lancet Oncology, vol.11, issue.11, pp.1048-1056, 2010.
DOI : 10.1016/S1470-2045(10)70230-8

P. Rolon, J. Smith, and N. Munoz, Human papillomavirus infection and invasive cervical cancer in Paraguay, International Journal of Cancer, vol.189, issue.4, pp.486-491, 2000.
DOI : 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S

C. Santos, N. Munoz, and S. Klug, HPV types and cofactors causing cervical cancer in Peru, British Journal of Cancer, vol.189, issue.7, pp.966-971, 2001.
DOI : 10.1054/bjoc.2001.1948

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375092

J. Roa, P. Garcia, and J. Gomez, HPV genotyping from invasive cervical cancer in Chile, International Journal of Gynecology & Obstetrics, vol.28, issue.(3), pp.150-153, 2009.
DOI : 10.1016/j.ijgo.2008.12.017

A. Ciapponi, A. Bardach, and D. Glujovsky, Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis, PLoS ONE, vol.15, issue.10, p.25493, 2011.
DOI : 10.1371/journal.pone.0025493.s005

J. Eluf-neto, M. Booth, and N. Muñoz, Human papillomavirus and invasive cervical cancer in Brazil, British Journal of Cancer, vol.69, issue.1, pp.114-119, 1994.
DOI : 10.1038/bjc.1994.18

N. Muñoz, F. Bosch, and S. De-sanjosé, The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in colombia and spain, International Journal of Cancer, vol.184, issue.5
DOI : 10.1002/ijc.2910520513

M. Correnti, F. Medina, and M. Cavazza, Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women, Gynecologic Oncology, vol.121, issue.3, pp.527-531, 2011.
DOI : 10.1016/j.ygyno.2011.02.003